Article Information
History
- May 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Chang Yi Wang, PhD1,*,
- Kao-Pin Hwang, MD, PhD2,3,
- Hui-Kai Kuo, MS1,
- Be-Sheng Kuo, PhD1,
- Hope Liu, PhD1,
- Kuo-Liang Hou, PhD1,
- Wan-Yu Tsai, MS1,
- Han-Chen Chiu, PhD1,
- Yu-Hsin Ho, MS1,
- Jennifer Cheng, MS1,
- Min-Sheng Wang, MS1,
- Ya-Ting Yang, MS1,
- Po-Yen Chang, MS1,
- Yea-Huei Shen, MD, MPH4 and
- Wen-Jiun Peng, PhD1
- 1UBI Asia, Hsinchu, Taiwan
- 2Division of Infectious Diseases, China Medical University Children’s Hospital, China Medical University, Taichung, Taiwan
- 3School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan
- 4StatPlus, Inc., Taipei, Taiwan
- ↵*To whom correspondence should be addressed: cywang{at}unitedbiopharma.com. Chang Yi Wang, on assignment at UBI Asia, Hsinchu, Taiwan, Tel: +886-963085800.
Posted May 05, 2022.
UB-612, a Multitope Universal Vaccine Eliciting a Balanced B and T Cell Immunity against SARS-CoV-2 Variants of Concern
